Home » Business, Health & Medicine, Manufacturing & Industry, Marketing & Sales, Pharmaceuticals & Biotech » Japan Diabetes Market – An Insight into the Oral Antidiabetics, Insulin and Diabetes Diagnostics Market in Japan
“Japan Diabetes Market Report: Patients, Prevalence, Oral Antidiabetics, Insulin and Diagnostics”
This new report from IMARC Group provides both current and future trends in the prevalence, demographical breakup, diagnosis and treatment of diabetes in Japan. This study serves as an exceptional tool to understand the epidemiology, market trends, therapeutic structure, competitive structure and the outlook of the Japanese diabetes market.

IMARC’s new report “Japan Diabetes Market Report: Patients, Prevalence, Oral Antidiabetics, Insulin and Diagnostics” provides an analytical and statistical insight into the Japanese diabetes market. The report provides both current and future trends in the prevalence, demographical breakup, diagnosis and treatment of diabetes in Japan. The research study serves as an exceptional tool to understand the epidemiology, market trends, therapeutic structure, competitive structure and the outlook of the Japanese diabetes market. This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who are planning to foray into the Japanese diabetes market in any form.

What we have achieved in this report:

Comprehensive situation analysis of the Japanese diabetes epidemiology and its dynamics:

Focus of the Analysis:

  • Historical, current and future prevalence of diabetes in Japan
  • Historical, current and future prevalence of type-1 and type-2 diabetes in Japan
  • Historical, current and future prevalence of diabetes in the urban and rural regions in Japan
  • Historical, current and future prevalence of diabetes among males and females in Japan
  • Historical, current and future prevalence of diabetes among various age groups in Japan
  • Historical, current and future diagnosis rates for diabetes in Japan
  • Historical, current and future drug treatment rates for diabetes in Japan


Comprehensive situation analysis of the Japanese Oral Antidiabetics market and its dynamics:

Focus of the Analysis:

  • Performance of the Oral Antidiabetics market in Japan
  • Performance of key classes
  • Performance of key players
  • Market outlook


Comprehensive situation analysis of the Japanese Insulin market and its dynamics:

Focus of the Analysis:

  • Performance of the Insulin market in Japan
  • Performance of key classes
  • Performance of key players
  • Market outlook


Comprehensive situation analysis of the Japanese diabetes diagnostics market and its dynamics:

Focus of the Analysis:

  • Performance of the diabetes diagnostics market in Japan
  • Market Segmentation
  • Key players
  • Market outlook


Table of Contents:

1 Research Methodology

2 Executive Summary

3 Diabetes Disease Overview

3.1 What is Diabetes?

3.2 Diabetes Diagnosis and Treatment

3.2.1 Diagnosis

3.2.2 Treatment

3.3 Diabetes Complications

4 Key Factors Driving the Diabetes Market in Japan

5 Japan Diabetes Epidemiology

5.1 Diabetes Population and Prevalence Rates

5.2 Population and Prevalence Rates by Diabetes Type (Type-1 and Type-2)

5.3 Population and Prevalence Rates by Region

5.4 Population and Prevalence Rates by Gender

5.5 Population and Prevalence Rates by Age Group

5.6 Diabetes Diagnosis and Drug Treatment Rates

6 Japan Diabetes Market

6.1 Historical Market Trends

6.2 Market Outlook

6.3 Market Breakup by Segment

6.4 Japan Oral Antidiabetics Market

6.4.1 Historical Market Trends

6.4.2 Market Breakup by Class

6.4.3 Market Shares of Key Players

6.4.4 Market Outlook

6.5 Japan Insulin Market

6.5.1 Historical Market Trends

6.5.2 Market Breakup by Class

6.5.3 Market Shares of Key Players

6.5.4 Market Outlook

7 Japan Diabetes Diagnostics Market

7.1 Historical Market Trends

7.2 Market Segmentation

7.1 Key Players

List of Figures

Figure 3 1: The impact of Diabetes in the Human Body

Figure 3 2: Diabetes Complications

Figure 4 1: Global: Breakup of Diabetes Patients by Region, (in %) 2015 & 2035

Figure 4 2: Japan: Overweight & Obese Population* (in Million), 2010, 2015. 2020

Figure 4 3: Body Mass Index and Relative risk of Type-2 Diabetes

Figure 4 4: Japan: Breakup of Total Population by Age Groups (0-14, 15-64 & 65+), (in %),

Figure 4 5 : Japan: Diabetes Prevalence By Age Groups, (in %),

Figure 5 1: Japan: Total Number of Diabetes Patients* (in 000), 2008-2015

Figure 5 2: Japan: Total Number of Diabetes Patients* Forecast (in 000), 2016-2020

Figure 5 3: Japan (Type1 & Type2): Total Number of Diabetes Patients* (in 000), 2008- 2015

Figure 5 4: India (Type1 & Type2): Total Number of Diabetes Patients* (in 000),2016-2020

Figure 5 5: Japan (Urban & Rural): Total Number of Diabetes Patients* (in 000), 2008 –  2015

Figure 5 6: Japan (Urban & Rural): Total Number of Diabetes Patients* (in 000), 2016 – 2020

Figure 5 7: Japan (Male & Female): Total Number of Diabetes Patients* (in 000), 2008 –  2015

Figure 5 8: Japan (Male & Female): Total Number of Diabetes Patients* (in 000), 2016 – 2020

Figure 5 9: Japan: Total Number of Diabetes Patients by Age Group (20-39), (40-59) & (60-79) (in 000), 2008 – 2015

Figure 5 10: Japan: Total Number of Diabetes Patients by Age Group (20-39), (40-59) & (60-79) (in 000), 2016 – 2020

Figure 6 1: Japan: Diabetes Drugs Market (in Million US$), 2008-2015

Figure 6 2: Japan: Diabetes Drug Market Forecast (in Million US$), 2016-2020

Figure 6 3: Japan: Diabetes Drugs Market Forecast: Breakup of Insulin and Oral Antidiabetics (in %), 2016-2020

Figure 6 4: Japan: Diabetes Drugs Market: Breakup of Insulin and Oral Antidiabetics (in %), 2008-2015

Figure 6 5: Japan: Oral Antidiabetics Market: (in Million US$), 2008-2015

Figure 6 6: Japan: Oral Antidiabetics Market: Sales Share of Key Classes (in %), 2008&2015

Figure 6 7: India: Oral Anti-diabetics Market: Sales Share of Key Players (in %),

Figure 6 8: Japan: Oral Antidiabetics Market: (in Million US$), 2016-2020

Figure 6 9: Japan: Oral Antidiabetics Market: Sales Share of Key Classes (in %), 2016 &2020

Figure 6 10: Japan: Insulin Market, (in Million US$), 2008-2015

Figure 6 11: Japan: Breakup of Insulin Market by Class (in %)

Figure 6 12: Japan: Insulin Market: Sales Share of Key Players (in %)

Figure 6 13: Japan: Insulin Market Forecast (in Million US$), 2016-2020

Figure 7 1: Japan: Diabetes Diagnostics Market (in Million US$), 2008-2015

Figure 7 2: Japan: Diabetes Diagnostics Market: Sales by Segment (in %)

Figure 7 3: Japan: Diabetes Diagnostics Market Forecast (in Million US$), 2016-2020

List of Tables

Table 3 1: Diagnosis of Diabetes

Table 4 1: Global: Diabetes Population Breakup by Country (in 000’s), 2015 & 2035

Table 4 2: Japan: Overweight &Obesity Statistics, 2010, 2015 & 2020

Table 4 3: Japan: Breakup of Total Population by Age Groups (0-14, 15-64 & 65+), (in Million),

Table 5 1: Japan: Total Prevalence &Number of Diabetes Patients*, 2008, 2015 & 2020

Table 5 2: Japan (Type1 & Type2): Total Prevalence & Number of Diabetes Patients, 2008, 2015 & 2020

Table 5 3: Japan (Urban & Rural): Total Prevalence & Number of Diabetes Patients, 2008, 2015 & 2020

Table 5 4: Japan (Male & Female): Total Prevalence & Number of Diabetes Patients, 2008, 2015 & 2020

Table 5 5: Total Prevalence & Number of Diabetes Patients by Age Group (20-39), (40-59) & (60-79) (In Millions), 2008, 2015 & 2020


To buy the complete report or to get a free sample, please contact:

IMARC Group Asia:
Email: apac@imarcgroup.com
Phone: +91-120-415-5099 

IMARC Group North America:
Email: america@imarcgroup.com
Phone: +1-631-791-1145

IMARC Group Europe, Middle East & Africa:
Email: ema@imarcgroup.com
Phone: +44-702-409-7331 

To know more please visit: http://www.imarcgroup.com/japan-diabetes-market


About IMARC Group

The International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

To know more about our company, please visit: http://www.imarcgroup.com/

Media Contact
Company Name: IMARC Group
Contact Person: Krishna Sharma
Email: sales@imarcgroup.com
Phone: +91-120-415-5099
Address:G B Nagar Noida Complex
City: Noida
State: Uttar Pradesh
Country: India
Website: http://www.imarcgroup.com/

Comments are closed.